Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Arrhythmia and Electrophysiology
Search: search_blue_button Advanced Search
Published Online
on August 5, 2009

Circulation: Arrhythmia and Electrophysiology. 2009
Published online before print August 5, 2009, doi: 10.1161/CIRCEP.109.859108
A more recent version of this article appeared on October 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2/5/548    most recent
CIRCEP.109.859108v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Borleffs, C. J. W.
Right arrow Articles by Schalij, M. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borleffs, C. J. W.
Right arrow Articles by Schalij, M. J.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Ablation/ICD/surgery
Right arrow Electrophysiology

Original Article

Predicting Ventricular Arrhythmias in Patients with Ischemic Heart Disease: Clinical Application of the ECG derived QRS-T Angle

C. Jan Willem Borleffs; Roderick W.C. Scherptong; Sum–Che Man; Guido H. van Welsenes; Jeroen J. Bax; Lieselot van Erven; Cees A. Swenne and Martin J. Schalij1

Leiden University Medical Center, Leiden, the Netherlands

* Corresponding author; email: m.j.schalij{at}lumc.nl

Background—In primary prevention implantable cardioverter defibrillator (ICD) patients, the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease (IHD).

Methods and Results—ICD patients (n=412, 361 male, age 63±11 years) with IHD and a left ventricular ejection fraction ≤ 40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle ≤ 90° (n=124, 30%) to patients with a planar QRS-T angle > 90° before device implantation. Furthermore, patients with a spatial QRS-T angle ≤ 100° (n=56, 14%) were compared to patients with a spatial QRS-T angle > 100º, prior to implant. For patients with a planar QRS-T angle > 90° as compared to ≤ 90°, the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI 1.1-5.2); a spatial QRS-T angle > 100° was associated with an adjusted hazard ratio of 7.3 (95% CI 1.0-53.8). Furthermore, a spatial QRS-T angle ≤ 100° exhibited a positive predictive value of 98% (95% CI 95-100%) for the prediction of an appropriate therapy-free follow-up.

Conclusions—A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with IHD. Furthermore, a spatial QRS-T angle ≤ 100º might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered.

Key Words: electrocardiography • tachyarrhythmias • Implantable cardioverter defibrillator • Ischemic heart disease • Primary prevention • ventricular arrhythmia